Q4 Results 2024 LIVE Updates: LIC, NMDC, AstraZeneca Pharma, Kirloskar Ind, Parle Ind, DCM Shriram more to announce earnings today financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
The brokerage has reduced its pharmacy target valuation from 25x to 22x, resulting in a lower SoTP by Rs 290 per share. "Keeping the hospital multiple intact (24x) and rolling over to FY26, our revised target price is Rs 7,300 (from Rs 7,500); we maintain ‘BUY," it said.
The scarcity of several medications in the US presents Indian pharma players with a great chance to expand market share, regulatory hurdles and industry dynamics allowing.
Novo Nordisk's parent invests in India's Manipal hospital chain moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.